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Abstract
Background: Unawareness or diminished awareness is present when a patient’s perception of obvious disease manifestations and impact differ from that of
observers such as clinicians or family members.
Methods: We examined studies that specifically investigate unawareness in Huntington disease (HD).
Results: Unawareness of motor, cognitive, behavioral, and functional aspects of HD has been documented throughout the disease course. This can occur at motor
and cognitive onset but is more pronounced as the disease progresses.
Discussion: We discuss the implications for diagnosis, symptom report at presentation, timing of diagnosis, acceptance of symptomatic care strategies, and reporting in
clinical trials. Assessments of work place competency, discrimination, driving, and the particular challenges of isolated patients without caregivers are described. Engaging
with a person who is unaware of their disease or its impact presents a number of conflicts, including maintaining the right to autonomy, privacy, confidentiality, and
independence while recognizing concerns for the wellbeing of the vulnerable person with HD and their caregiver when the unaware person refuses assistance.
Unawareness is seen increasingly as neurologically based due to the impairment of functional networks, predominantly in nondominant frontostriatal pathways.
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Introduction
Unawareness or diminished awareness is present when a patient’s
perception of obvious disease manifestations differs from that of
objective observers. Unawareness often accompanies Huntington
disease (HD) and is recognized by clinicians and family members
alike. It becomes obvious as premanifest CAG (cytosine adenine
guanine) repeat expansion carriers move toward a definitive diagnosis,
but unawareness can be seen throughout the disease course. In the
past, some have described this as denial of illness and a coping
mechanism. However, unawareness is increasingly seen as neurobio-
logical in origin, possibly a consequence of impaired nondominant
frontostriatal pathways.1–5
Clinically, unawareness is witnessed across all disease domains
(motor, cognitive, behavioral, and functional) and possibly for different
disease features at different disease stages. For example, unawareness is
not only seen accompanying involuntary movements, but can also be
observed for dysphagia, falls, irritability, impaired organizational skills,
and impaired ability to drive. It can be a difficult situation for the
physician who recognizes signs and impact of disease before any
acknowledgement by the unaware person. This is especially when an
isolated person comes to clinic visits without an accompanying person
and therefore a corroborative history and when disease changes pose a
risk.
In this review, we examine studies that specifically investigate
unawareness in HD. In addition, we review the means of assessment
and pathophysiology and explore care implications and workplace,
legal and ethical issues. We conclude by discussing patients with HD
with preserved awareness and implications for future research.
Definition and illustrative case studies
The terms anosognosia (described first by Babinski), unawareness,
lack of awareness and insight, and denial are often combined in the
literature2,4,6–8 for HD and other neurodegenerative diseases. Distilling
these definitions, unawareness is present when: 1) the manifestations of
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disease and the consequences are obvious to and can be documented
by an observer, but 2) the individual underestimates or does not report
experiencing symptoms or notice these changes or the impact. The
person with HD may also rate their own abilities better than another
observer (companion, caregiver, or clinician) and be unconcerned
(anosodiaphoria).9–12 Unawareness may extend beyond the person’s
lack of awareness of self. This may include unawareness of others’
needs and the changed relationship between the person and his/her
environment. Unawareness compounds the effect of manifestations
(e.g., disordered empathy and impaired Theory of Mind seen in
HD).13,14 Unawareness may impair the perception of symptoms
unrelated to HD, including pain.15
These definitions of unawareness are best illustrated by case examples:
Case 1: A patient with behavioral, cognitive, and motor manifesta-
tions was diagnosed some years before they were admitted voluntarily
to the HD unit. After a violent incident, staff counseled the person that
the outburst was HD related. The person flew into a rage and declared
that he/she did not have HD.
Case 2: A law enforcement officer with HD who knew the correct
behavior chose to cross a six-lane highway away from a crossing on a
number of occasions. This seems more than impulsivity or bad
judgment and included unawareness of self and environment. The
person was unconcerned and offered no explanation for his repeated
jay-walking.
Case 3: A male well-acquainted with the course of HD in his family
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compensation money on a farm distant from services that he could
never look after: an example perhaps that the unawareness of HD may
extend to other afflictions affecting the person.
Summary of studies on unawareness in HD
Compared with Alzheimer disease (AD) and frontotemporal
dementia (FTD), unawareness in HD is understudied. Table 1 lists
chronological studies that can be grouped according to unawareness of
motor features4,5,16–19 and cognitive, behavioral, and functional
manifestations.4,9–12,20 Two studies examined patient and caregiver/
proxy perceptions of disease impact on Quality of Life (QoL).21,22
Most studies were designed to identify unawareness by finding
discrepancies between the person with HD and an observer but, by
definition, unawareness is superimposed on other disease features. Few
compared the aware and unaware patients to controls for other disease
features. Deckel et al4 compared HD persons scoring high and low on
an anosognosia scale, but the sample size was small. McCusker et al17
analyzed awareness/unawareness at first motor diagnosis in
PREDICT-HD (Neurobiological Predictors of Huntington Disease),
a large cohort study of mutation carriers. Only the retrospective data
analysis studies from PREDICT-HD10,17 included imaging that could
potentially identify the pathological substrate.
Tests used to measure unawareness
A number of test batteries were used in the prospective studies designed
specifically to rate degree of unawareness.4,5,9,11,12,18–22 These include the
Free and Cued Selective Reminding Test (FCSRT), Wisconsin Card Sort
Test (WCST), Dysexecutive questionnaire (DEX), total Frontal Systems
Behavior Scale (FrSBe, participant and companion), the Motor
Impairment Scale (MIS), and the subjective memory questionnaire scale
given to patients and observers. In most studies, disease stage was
established using the history, motor, behavioral, and Total Functional
Capacity sections of the Unified HD Rating Scale (UHDRS).
Motor studies
Deckel et al administered a simple eight-item anosognosia scale to 19
HD patients. The scale, a self-report rating of cognitive and motor
abilities, was compared with ratings by clinicians on two occasions and
14 non-HD controls who presented for neuropsychological testing for
other reasons. Based on their score on this scale, 6 HD patients were
identified with ‘‘high anosognosia’’ (HA) and 11 with ‘‘low anosognosia’’
(LA). The HA patients were found to be more impaired upon formal
neuropsychological testing, although it was unclear whether the HA and
LA groups were at different disease stages. The WCST separated the
two groups. The authors suggested this might implicate involvement of
the dorsal-lateral prefrontal pathway, which is activated by WCST.
In contrast, Snowden et al5 suggested that unawareness of chorea
was a physiological phenomenon and not due to cognitive or
psychological factors. Their conclusion was based on the observation
that HD persons who were not aware of the chorea did recognize its
consequences. The authors further postulated that patients may not
receive internal feedback of the chorea and therefore had no subjective
experience of it. In support of this, they reported that chorea was not
generally reported over a range of disease stages or associated with a
particular pattern of cognitive impairment. Contrary to this hypothesis
is the observation that some people are aware of their movements
whereas some seem unaware of consequences.
Vitale et al19 explored this further by recording the self-reported
Abnormal Involuntary Movement Score for people with chorea in HD
versus people with dyskinesia in Parkinson Disease (PD). In HD,
unawareness of chorea and the impact on motor function was related
to disease duration. In contrast, unawareness of dyskinesia in PD was
not related to the Unified PD Rating Scale score, dyskinesia score, or
disease duration.
Sitek et al18 also compared patients with HD patients with chorea
and people with PD-related dyskinesia. People with HD were found to
underreport motor deficits compared to the other group. This disparity
was not as evident for perception of activities of daily living, a finding
that supported the conclusions of Snowden et al.5
McCusker et al17 retrospectively analyzed PREDICT-HD data and
identified unaware and aware groups at the time of motor diagnosis. In
this study ,50% of patients were unaware of motor features at motor
diagnosis. However two groups, one aware at motor diagnosis and one
with motor complaints prediagnosis, were aware at a time when mild
motor signs would be unlikely to have an impact and this does not
support the hypothesis that only motor features with impact are
recognized. The unaware group reported significantly fewer depressive
symptoms. Magnetic resonance imaging (MRI) striatal volume loss was
greatest in the more aware and diagnosed group. The significance is
uncertain, as the limited imaging of the PREDICT-HD study did not
specifically incorporate the areas thought to be involved in unaware-
ness.
Cognitive and behavioral
Chaterjee et al9 explored caregiver and patient agreement for
depression, apathy, and irritability using standardized scales.
Agreement for depression was fair to moderate but less marked in
milder disease. Agreement for apathy was worse for more advanced
disease, and agreement for irritability was ‘‘fair at best’’ regardless of
disease stage.
Ho et al11 examined executive dysfunction using the Behavioral
Assessment of the Dysexecutive Syndrome (BADS). Patients with HD
were able to rate their caregivers’ behavior in a similar manner to the
caregivers, but their rating of their own behavior differed significantly
from their caregivers. This suggests a deficit in self-awareness.
However the caregiver usually would not have dysexecutive function
and therefore would be likely to be rated in the same way. Impaired
perception could be an alternate explanation for this disparity between
patient self-rating and caregiver rating of the patient. When asked to
rank three aspects of behavior (cognition, self-regulation, and insight),
people with HD ranked impaired cognition as the greatest concern,
while caregivers ranked cognition and lack of insight as equally
problematic. Overall, caregivers’ rating of patients correlated better
with UHDRS clinical measures of disease severity.
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Hoth et al12 took a similar approach using the Patient Competency
Rating Scale (PCRS)23 and eight motor items generated for the study.
Again, collaterals’ ratings correlated with neurological examination
scores, dementia ratings, memory performance, and some measures of
executive function (WCST perseverative responses and symbol digit),
but patients’ self-rating did not. Interestingly, better rating of one’s
own impairments was associated with depression. The authors’
conclusion was that unawareness protects against depression, and we
reported a similar finding among a very early group of HD motor
phenoconverters.17
Duff et al10 compared ratings by 745 mutation carriers and 163
noncarriers and companions on the modified FrSBe (apathy,
disinhibition, and executive dysfunction), from the PREDICT-HD
study. The companion scores correlated with markers of disease
progression, including MRI striatal volume, through the prodrome. In
contrast, HD carriers regarded themselves as less impaired within 5
years of diagnosis, whereas the companions rated them as more
impaired.
Cleret de Langavant et al studied individuals with early to mild
HD.20 On a subjective memory questionnaire, patients with cognitive
impairment did not rate themselves differently from those without
cognitive impairment. Reduced awareness of memory deficit was
related to disease progression but not depression. The authors agreed
with others that unawareness of deficit might vary for different
domains at various stages of disease progression.
QoL
Kaptein et al22 studied the impact of illness perceptions on QoL in
51 spouses/partners and patients with relatively early HD, using the
Illness Perception Questionnaire (IPQ) and the Medical Outcome
Survey (MOS) of the Short Form (36) Health Survey (SF-36). Spouses
perceived more symptoms and reported less control than patients,
indicating patient unawareness. Patients’ illness perception and that of
their partners had an impact on QoL. The vitality (energy and fatigue)
subscale score for the MOS SF-36 was associated with partner belief in
long duration and a cure, and the patient’s belief of long disease
duration.
Hocaoglu et al21 investigated health-related QoL (HrQoL) by
comparing proxy assessments and patient self-ratings for subjects at
different disease stages. Proxy ratings were similar to patient ratings for
the overall score on the HD QoL. The better the patient report of
QoL, the better the proxy report. On some specific subscales (cognitive
and specific physical and functional scales) proxies rated HrQoL worse
than patients rated themselves. The discrepancy was greatest in
moderate disease.
To date, most studies of unawareness have focused on establishing
the presence of unawareness in HD by documentation of the
discrepancies between patient and observer reports. Unawareness is
documented across varying disease domains and with few exceptions
correlates with disease progression but is evident at the earliest
stages.
Unawareness and disease stage
In the premanifest group, the examiner may find definite but subtle
motor signs that constitute a clinical diagnosis, including some signs
without associated symptoms (e.g., early eye movement disorder). Fifty
percent of people in some studies at this time in their HD course may
be classified as unaware.17 However, others with similar motor scores
and another prediagnosis group reported motor symptoms. This would
be evidence against the physiological hypothesis as these participants
were aware of relatively subtle changes that would be unlikely to have
a consequence. In contrast, Justo et al16 found that some participants
from each of the early HD, premanifest HD, and control groups were
unaware of movements. This included some with nonpathological
movements in the control group. However, these were undefined
phenomenologically and only occurred intermittently and were likely
less noticeable. This observation therefore may or may not support the
concept that only a motor abnormality that impacts function produces
symptoms.
Unawareness of executive dysfunction has been documented in the
premanifest population in PREDICT-HD.10 Cleret de Langavant et
al20 found those with early HD were more aware of their memory
changes than proxies in the study, but patient awareness of memory
impairment lessened with disease progression.
The degree and spectrum of unawareness in the HD population
may not be fully captured in studies to date, as patients with
unawareness are less likely to attend formal clinics or join research
programs or patient and family support groups.
In the studies we reviewed, patient unawareness in a range of
domains correlated with increasing HD severity. Reports of disease
impact by the observer correlates well with objective measures of
impairment.
Pathophysiology
To date, most knowledge of the pathophysiology of diminished
awareness in the dementias comes from specific studies in AD and
FTD.24–28 Orbitofrontal, temporoparietal, and cingulofrontal changes
have been identified on imaging studies. In HD, the likely neural
substrate is implied from general imaging and pathological studies in
which impairment of frontostriatal pathways is well documented,
particularly in the studies of progression in the premanifest
phase.10,17,29–32 In addition, evidence from a number of reports that
right basal ganglia infarction results in neglect and denial of deficit and
lack of concern is well documented.4 Unawareness covers a number of
domains, so a different pathological substrate is likely for a particular
deficit. 8 Specific imaging/pathological studies in those with and
without impaired awareness in established HD have not been
performed. The database inquiry studies in premanifest disease10,17
included imaging but were not specifically designed to capture
unawareness in detail. Taking these and other dementia studies into
account, one must agree with the conclusion of Sitek et al: ‘‘attribution
of deficient self-awareness of motor symptoms exclusively to the
orbitofrontal-limbic atrophy in HD may be a simplification of this
complex phenomenon and requires further empirical evidence.’’18
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The pathophysiological substrate has not been studied for
unawareness in HD but is inferred from studies of other disease states
in which unawareness is prominent and includes frontostriatal
pathology but may vary for different HD domains.
Care implications
The primary ethical dilemma for neurologists and other care
providers is the balance between a patient’s family’s concern regarding
care and safety and maintenance of patient autonomy, privacy, and
engagement in the context of unawareness.
Unawareness has a considerable impact on the timing of diagnosis,
as well as caregiver and family relationships.9,22 An unaware individual
may not present for assessment or care. This may not be important
unless the clinical changes pose a risk or are amenable to symptomatic
interventions. However, among those without a known family history,
delays in disclosure of risk to genetic family members can have
significant consequences. Unaware individuals who do not want to
disclose the risk of HD to other family members create another ethical
conflict between confidentiality for the individual and the rights of
those at risk to know.
Unawareness can also form a barrier to care delivery. People who
are unaware tend not to attend clinics, and advice and support for the
caregiver may not be optimal if the person with HD has not been
assessed. We developed an outreach model of multidisciplinary care so
that nursing staff and social workers trained in HD care, including
behavior management, can visit at home or at the care facility. They
act as ‘‘key workers’’ and liaise with the neurologists and members of
the multidisciplinary care team. The situation is even more complex if
these approaches are refused and when unawareness is superimposed
on other behavioral and cognitive impairments including irritability,
aggression, apathy, and depression.3,9,33,34 A formal guardianship
order may be needed as a duty of care.4,35
In patients with diminished awareness, some treatments may not be
appropriate (e.g., when the person is unaware of chorea). However,
many symptoms and manifestations of HD are amenable to
interventions.33 These include adoption of a healthy lifestyle; advice
about diet; swallowing assessment and exercise therapy; treatment of
depression and psychosis; home modifications and provision of aids for
walking; and links to supportive care networks, a family physician, and
research projects.
Lack of awareness also has substantial impact on caregivers. The
patient may refuse intervention and assistance and have no perception
that the caregiver needs respite or that they are unable to continue
care. The caregiver usually initiates the patient’s move to 24-hour
inpatient care. This is particularly difficult if the person does not accept
the need for later stage care. Caregivers may have difficulty in
accepting this resistance to respite as part of the disease process.
In managing unawareness or diminished awareness, it is first
important to recognize that this is frequent in HD and to encourage
caregiver reports if the person with HD allows it. It is helpful to explain
the nature of unawareness to caregivers and family members,
including unawareness of cognitive impairment. Unawareness may
be managed with a very gradual, nonconfrontational introduction of a
care plan that preserves independence for the person with HD. Most
studies have shown that unawareness has a greater impact with disease
progression. Engaging the person early in the prodrome by offering
assessments, review, research updates, and support and education is
likely the best approach.
Unawareness delays diagnosis and care including treatment of
modifiable symptoms and manifestations but also access to home
services, caregiver support, and accommodation facilities if needed.
Unawareness has a significant impact on the caregiver’s ability to cope.
An out-of-clinic outreach approach to care to engage with the unaware
person is helpful.
Unawareness of functional and workplace competency and
discrimination
To date, studies of discrimination in HD predominantly involve
premanifest individuals. While a person’s self-report of discrimination
must be taken seriously and their employment protected, report of
work performance and safety factors need to be considered. Some
individuals with diminished ability to perform their usual employment
safely may have reduced awareness and are unable to accept necessary
changes to employment.
Both physical and cognitive impairments pose a risk in most
occupations. While not a concern unless safety is compromised, the
person with diminished awareness may not recognize the need for
medical review with workplace duties in mind. The doctor’s situation is
even more difficult when a self-employed worker attends an
appointment, especially if there is no companion and they refuse
appropriate assessments.
This dilemma extends to a range of functions beyond the workplace
that carry risks for the unaware person and others. These include
impact on skills affected by cognitive decline (e.g., managing financial
affairs). Driving is a particular concern if the possibility of reduced skill
is unrecognized and the need for testing is rejected.36,37 Driving
restriction can make it very difficult to maintain an ongoing doctor–
patient relationship.
Discrimination in the workplace must be guarded against. However
self-report and even caregiver reports of workplace competency could
be unreliable. Full assessment that takes into account the nature of the
person’s employment and other risk-prone activities (e.g., driving and
financial management) can be difficult if unawareness is present and
the need for assessment is not accepted.
Legal and ethical aspects of unawareness
The effect of impaired awareness on competency and capacity to
make decisions needs to be recognized as an integral part of life and
care decisions. Most of the discussions of the ethical implications of
impaired awareness are in the Alzheimer’s disease and dementia
literature.8,38 The multifaceted nature of competency, capacity, and
awareness is emphasized in these studies.8,38 The HD person is very
vulnerable, especially when isolated. Errors of judgment in relation to
life decisions are in part related to diminished awareness of the disease
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process. An early power of attorney agreement is advised, as well as an
up-to-date will and care directives, with the provision for periodic
review. Poor planning and apathy compounded by unawareness may
require appointment of a legal guardian or surrogate decision maker.
Even then, the guardian may be powerless to act for an unaware
person with major behavioral disturbance and withdrawal from
medical and social contact.
The relatively long disease duration adds another layer of
complexity. Earlier in the disease course, a person with HD may
indicate through living wills and other predetermined directives how
they wish to be treated in the future. However, they may not view HD
in the same way as the disease progresses. With progression, their
perception of QoL may also differ from others’, including those
entrusted with making decisions for them. For instance, some very
advanced HD patients, with little awareness of disease impact, lead a
relatively happy and content life that they may not have imagined
earlier. It is important that the person is involved when care decisions
and end-of-life plans are discussed, and if possible included in a routine
review process.22
Finally, the authors of studies of unawareness of motor features in
HD, in particular chorea, emphasize that it may not be ethical to offer
antichoreic agents when the person is not aware of or bothered by
movements. This is particularly so when medications cause side effects.
The treatment of behavioral manifestations and depression or other
disease features with a potential for harm is a different matter, and a
duty of care could be argued.
Unawareness has a significant effect on decision making and must
be considered when competency and capacity are assessed.
Unawareness may change the person’s perspective of disease impact
and requires regular revision of care directives.
People with HD and preserved awareness
While unawareness poses significant problems, there is a group
with more acute awareness of disease manifestations, even at early
stages.5,16,17 People aware of motor signs at phenoconversion in
prodromal HD were more likely to experience depression and a
greater perception of progression than the unaware group.17 This
link between depression and awareness has also been reported in
other neurodegenerative diseases and is associated with a greater risk
of suicide.39,40 Most instances of suicide in our clinic population,
including some very violent deaths, occurred in people with
preserved awareness of disease and the consequences for themselves
and others.
There is also a clinically observed group that is hyperaware. After
testing positive as mutation carriers, they suspect HD onset with any
movement or memory lapse. Anxiety is the most frequent outcome to
impact on QoL after genetic testing.41 In some people, this interferes
with daily life over years, despite pre- and posttest counseling. For
others, this may represent nonmotor onset.
Some people, usually in earlier stages of HD, retain awareness that
is associated with anxiety, depression, and greater suicide risk.
Implications for research
Currently, there is no specific inclusion of unawareness in the HD
behavior scales (UHDRS for Behavior and Problem Behavior
Assessment [PBA]). There are provisions to include a corroborative
history, but it is important to take unawareness into account.
Otherwise, assessment of disease onset, symptoms, progression, and
trial outcome could be affected. Based on the studies listed, self-report
of history and progression is inaccurate in 30–50% of cases. Thus, self-
report of treatment response from trial medication or placebo may be
misleading and result in inaccurate trial outcomes because up to 50%
of people will be unaware of disease manifestations and impact.
Conclusion
Unawareness in HD requires further specific studies to define the
best tools for assessment, pathophysiology, and associations with the
disease features at different disease stages. Our current motor-based
diagnostic criteria need review42,43 because cognitive and behavioral
symptoms and manifestations often precede motor onset,10,17,44 and
unawareness is often included in these symptoms. Maintenance of
patient autonomy by avoiding patronizing intrusions while still
recognizing the impact of diminished awareness is a major challenge
in caring for people with HD. When the many facets of unawareness
compound the challenges of care, HD is indeed a confronting,
complex condition.
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